Nano-immunomodulators: prospective applications to combat drug resistant bacterial infections and related complications
| dc.contributor.author | Chand, Umesh | |
| dc.contributor.author | Kushawaha, Pramod Kumar | |
| dc.date.accessioned | 2024-01-21T10:26:46Z | |
| dc.date.accessioned | 2024-08-13T11:19:33Z | |
| dc.date.available | 2024-01-21T10:26:46Z | |
| dc.date.available | 2024-08-13T11:19:33Z | |
| dc.date.issued | 2023-11-08T00:00:00 | |
| dc.description.abstract | Antimicrobial resistance (AMR) is a growing problem in our healthcare sector, it can make infections more difficult and expensive to treat and lead to treatment failure and increased risk of death. Currently, at least 700,000 people worldwide die each year from AMR. Alternative methods for mitigating drug-resistant bacterial infections are desperately needed because of the unacceptably low rate of conventional antibiotic discovery. Therefore, the implementation of various therapeutic strategies is necessary to deal with drug-resistant bacteria and immunomodulation is one of them which is highly encouraged through various studies. Immunomodulators are different biological or synthetic substances that possess the capability of inducing, suppressing, or overall modulating the innate and adaptive immune system. Some phytochemicals, including flavonoids, glycosides, polysaccharides, terpenoids, essential oils, peptides, synthetic molecules, and synthetic biomaterials, can play a crucial role in the fight against bacterial infections directly or indirectly by enhancing the activity of existing antibiotics or by boosting immunity. Nanotechnology can be used to modulate immune responses through various fabrication methods and strategies of design and for drug formulation by encapsulating potential compounds/molecules in the form of nanoparticles and by surface modification or capping of nanomaterials. This approach can improve drug solubility, stability, and bioavailability, reduce toxicity, and help to increase the effectiveness of drugs against resistant microorganisms. This review aims to provide current developments in the field of immunomodulators of different origins that can be combined with nanotechnology and exploited as potential future drugs or adjuvants to fight drug-resistant bacterial pathogens. � 2023 Informa UK Limited, trading as Taylor & Francis Group. | en_US |
| dc.identifier.doi | 10.1080/09205063.2023.2265619 | |
| dc.identifier.issn | 9205063 | |
| dc.identifier.uri | http://10.2.3.109/handle/32116/3126 | |
| dc.identifier.url | https://www.tandfonline.com/doi/full/10.1080/09205063.2023.2265619 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Taylor and Francis Ltd. | en_US |
| dc.subject | adjuvants | en_US |
| dc.subject | antibiotics | en_US |
| dc.subject | Drug-resistance | en_US |
| dc.subject | immunomodulators | en_US |
| dc.subject | nanotechnology | en_US |
| dc.subject | phytochemicals | en_US |
| dc.title | Nano-immunomodulators: prospective applications to combat drug resistant bacterial infections and related complications | en_US |
| dc.title.journal | Journal of Biomaterials Science, Polymer Edition | en_US |
| dc.type | Review | en_US |
| dc.type.accesstype | Closed Access | en_US |